Episode 2: How can your Digital Health Technology (DHT) be reimbursed in Swizerland? episode artwork

EPISODE · Apr 24, 2025 · 12 MIN

Episode 2: How can your Digital Health Technology (DHT) be reimbursed in Swizerland?

from Navigating Swiss Market Access #medtech #digitalhealth · host Gurmit Sandhu & Angelina Rau

In this episode, we explore the reimbursement landscape for digital health technologies (DHTs) in Switzerland with Angelina, offering an introductory overview of key pathways to market access.We focus on the inclusion of DHTs in Switzerland’s compulsory health insurance system ("OKP") and touch on the essential reimbursement criteria—known as the "EAE criteria" or "WZW-Kriterien":Effectiveness (Wirksamkeit)Appropriateness (Zweckmässigkeit)Cost-effectiveness (Wirtschaftlichkeit)We also highlight practical challenges, identify useful public resources and documentation from the Swiss Federal Office of Public Health (FOPH/BAG), and discuss what innovators should consider when navigating the Swiss healthcare system.This episode is ideal for developers, investors, and stakeholders interested in bringing digital solutions to the Swiss market.Future episodes will offer a deeper dive into the regulatory requirements associated with the EAE criteria for securing reimbursement under the compulsory health insurance system.GET IN TOUCH:Feedback? We’re listening. Send us a message on LinkedIn:  https://linkedin.com/in/gurmitsandhu   | https://linkedin.com/in/angelina-rauShare your experience, feedback, “pain points”  or success with market access & reimbursement of digital health technology #medtech  #meddevice : on the comments section below or DM us on LinkedInDo you know someone who would be a great guest for us to interview? Let us know via LinkedIn | Topics that you want us to focus on. Drop us a comment below!What to Read:  Reimbursement guide on digital health applications within the Swiss healthcare system | Created in collaboration with experts in insurance, law, pharma, and industry including Angelina Rau | Free access, in Eng & De =>https://swisshealthcarestartups.com/en/reimbursement-guide Kohler, Stefan / Rau, Angelina, Vergütung digitaler Gesundheitsanwendungen in der Schweiz, Life Sciences Recht Stämpfli, LSR 1/2023, S. 13-22, Januar 2023       Sandhu G, Mohamed Ghazali IM, Laurenzi E, Miho E. PP22 A Dashboard To Support The Value Assessment Of Digital Health Technologies F...

Episode metadata supplied by the publisher feed · Published Apr 24, 2025

Embed this episode

In this episode, we explore the reimbursement landscape for digital health technologies (DHTs) in Switzerland with Angelina, offering an introductory overview of key pathways to market access. We focus on the inclusion of DHTs in Switzerland’s compulsory health insurance system ("OKP") and touch on the essential reimbursement criteria—known as the "EAE criteria" or "WZW-Kriterien": Effectiveness (Wirksamkeit)Appropriateness (Zweckmässigkeit)Cost-effectiveness (Wirtschaftlichkeit)We also highl...

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Episode 2: How can your Digital Health Technology (DHT) be reimbursed in Swizerland?

0:00 12:15

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Navigating Swiss Market Access #medtech #digitalhealth?

This episode is 12 minutes long.

When was this Navigating Swiss Market Access #medtech #digitalhealth episode published?

This episode was published on April 24, 2025.

Can I download this Navigating Swiss Market Access #medtech #digitalhealth episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!